Cohance Lifesciences
NSE: COHANCE
Healthcare
₹462.3513.202.78%(1D)
Performance Stats for Cohance Lifesciences
Day Range
Low: ₹457.00
High: ₹481.05
52 Week Range
Low: ₹266.70
High: ₹1038.90
Open Price
477.90Previous Close
475.55Volume
1638217.00Open Price
477.90Previous Close
475.55Volume
1638217.00Fundamentals of Cohance Lifesciences
ROCE
15.94%
EPS
₹5
Dividend Yield
0%
P/E Ratio
108.7
P/B Ratio
12.75
Debt to Equity
0.04
Current Ratio
2.24
Sales Growth
-23.73%
Profit Growth
-62.09%
EBIT Growth
-59.68%
Financials of Cohance Lifesciences
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Cohance Lifesciences
About Cohance Lifesciences
Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated on November 6, 2018. The name of the Company has been changed to Cohance Lifesciences Limited w.e.f. May 7, 2025. Cohance Lifesciences Ltd is an integrated...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Aarey Drugs And Pharm | ₹78.1 3.09% |
| Aarti Drugs | ₹418 0.78% |
| Aarti Pharmalabs | ₹817 1.48% |
| Abbott India | ₹26250 0.5% |
Most Viewed Stocks
Sorry, option data not Found For this Stock :(
Events Related to Cohance Lifesciences
AGM
Sep 17, 2026
Board Meeting
Aug 5, 2026
Board Meeting
May 12, 2026
Board Meeting
Apr 27, 2026
Board Meeting
Feb 12, 2026
News About Cohance Lifesciences
Cohance Lifesciences Stock Jumps Over 2% Despite Poor Q1 Earnings; Here"s Why
Aug 6, 2026
Cohance Lifesciences Q1 Review: Brokerages Split After Earnings Slump — Check Potential Upside, Target Price
Aug 6, 2026
10 Nifty 500 stocks plunge over 50% from 52-week highs. Do you own any?
Jul 9, 2026
Cohance Q4 Profit Slumps 72%, ICICI Securities Downgrades to Reduce"
May 13, 2026
Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4
May 13, 2026
